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Chronic pelvic pain in women is a common and dis-
abling illness caused by numerous organic pathologies
usually accompanied by varying psychological dysfunc-
tions. Many patients may receive misdiagnosis, misdi-
rected therapies, or do not seek help at all. Pelvic con-
gestion may be responsible for pain in patients without
more common diseases, such as endometriosis and
pelvic adhesions, among others. Our view of this condi-
tion is evolving. In the United States, this medical condi-
tion remains controversial. More recent research from the
United Kingdom has caused a fresh look at the diagno-
sis and treatment of chronic pelvic pain produced by
pelvic congestion. Potentially, many patients may benefit
from a reconsideration of this approach.
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INTRODUCTION
Chronic pelvic pain in women is a common and dis-
abling condition. It is defined as pain that has been pres-
ent for 6 months or longer. In contrast to episodic and
acute pain, chronic pain is almost continuous and unre-
sponsive to conventional diagnosis and treatment. If
unrelieved, it may result in long-term disability, depres-
sion, and neurological changes.
Two to 10% of all gynecologic office consultations are for
chronic pelvic pain. Twenty percent of all laparoscopies
are performed for chronic pelvic pain. It is estimated that
10 million women suffer from this condition and that 7
million do not seek help. Up to 61% of patients are found
to have no explanation for their pain.
The economic impact of this condition is astonishing.
The annual medical cost for diagnosis and treatment of
chronic pelvic pain is estimated to be about $1.2 billion.
The cost of lost productivity in these patients is estimat-
ed to be $15 billion annually. The most commonly made
diagnosis in chronic pelvic pain is endometriosis (31%).
The majority are undiagnosed or improperly diagnosed.1
In the majority of women with no obvious pathological
cause for their pain, they may be suffering from pelvic
congestion syndrome (PCS). It is a diagnosis that was
proposed over 100 years ago, but is only recently regain-
ing legitimacy. Pelvic congestion is the presence of
enlarged venous complexes of the reproductive tissues
with impaired circulation and drainage. Richet2 is credit-
ed with first describing this condition as a case of “tubo-
ovarian varicocele.” Before the days of laparoscopy and
venography, Howard Taylor3 described this syndrome
and gained some credibility in the medical community of
the 1950s. However, due to assumptions regarding the
psychosexual component of this illness, and the fact that
stress always aggravates the pain, many physicians saw
this as a purely psychosomatic illness. The resurgence of
pelvic congestion as a legitimate cause of chronic pelvic
pain is due to the elegant and systematic work of Beard’s
group4 at St. Mary’s Hospital in London. Starting in the
1970s and proceeding through the present, the clinical
characteristics, methods, and criteria for diagnosis and
psychological components have been addressed in the
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United Kingdom without totally being accepted by the
American academic and practicing community.
ETIOLOGY
The possible etiologies of chronic pelvic pain caused by
pelvic congestion have been classified by El-Minawi.5
They are classified into 5 categories. These are not con-
sidered to be complete and do not singularly explain all
the clinical findings of pelvic congestion, each failing in
some respect. 
Anatomic Dysfunction
Pelvic varicosities are thought to be the effect of gravity
on an incompetent venous valvular system. The resultant
stasis produces the congestion and pain that is associat-
ed with this condition. Pregnancy increases the capacity
of the pelvic veins by 60%. When combined with venous
kinking of a malpositioned gravid uterus, this is likely to
lead to the venous stagnation, flow reversal, and vari-
cosities seen. Parity is a known risk factor in the devel-
opment of this syndrome.6 Allen and Master’s7 controver-
sial theory regarding a “fascial defect” producing uterine
malposition and congestion has been discounted.
However, a relationship has been established between
retroversion of the uterus with pelvic pain and dilated
pelvic veins.8
Orgasmic Dysfunction
When the female is sexually stimulated up to, but not
reaching, orgasm (the plateau phase of female sexual
response), some pain caused by the vasocongestion may
be felt in the pelvic viscera. Whether this can produce
permanent vascular changes in unknown.
Psychosomatic Dysfunction
Taylor3 wrote that “psychiatric disturbances, usually of an
emotional character, are a common accompaniment of
pelvic congestion. . . .” It was his opinion that an impor-
tant factor in the etiology of pelvic congestion was “the
effect of a primary state of emotional tension” on the
smooth muscle and secretory cells of the pelvis in pro-
ducing psychosomatic disturbances. This caused pelvic
congestion to be looked at as a purely psychiatric condi-
tion (pelipathia vegetativa). Beard and colleagues9 par-
tially confirmed this by finding that women with pelvic
congestion tended to be more neurotic and in less satis-
fying relationships. As El-Minawi5 points out that this
proposition brings up the old saw regarding the “chick-
en and the egg.” It is true that these women will have
some psychological overlay, but we have learned from
our study of chronic pain in men and women that the
stress of chronic pain itself induces many of these social
and psychological consequences.
Hormonal Dysfunction
Women with pelvic congestion have a higher incidence
of multicystic ovaries, enlarged uteri, and thickened
endometrium, which all may be hormonally induced.
Taylor3 and Beard mentioned the possibility that this
condition might be related to hormonal sensitivity
because it is virtually unknown in the postmenopausal
female. Reginald10 found that by inhibiting estrogen’s
effect with medroxyprogesterone acetate (MPA) a veno-
graphically demonstrable diminution of pelvic conges-
tion occurred. The majority of these women experienced
good relief of their symptoms when compared with con-
trols. 
Iatrogenically Induced Dysfunction
In 1 series, 60% of patients with pelvic congestion were
found to have had a tubal ligation. These patients were
also found to have a greater volume of peritoneal tran-
sudate, and this fluid contained higher levels of 6 keto-
prostaglandin alpha than that in controls. These patients
were symptomatic 16% to 39% of the time. Another pos-
sible iatrogenic cause is the use of intrauterine devices.
One study demonstrated venographically (95%) and
laparoscopically (52%) an association between PCS and
the Lippes loop.5 Larger studies have yet to verify any of
these causes.
PATHOPHYSIOLOGY
The rich anastomotic plexuses of the pelvic viscera
include ovarian, paraovarian, uterine, vesicle, rectal, and
vulvar veins. The vulvar and uterine veins normally drain
into the internal iliac vessels. The left ovarian vein drains
into the left renal vein, and the right ovarian vein drains
into the vena cava directly. Vascular connections exist
between the vesicle and rectal venous complexes as well
as the upper thigh. These channels are relatively valve-
less and are gravity and vascular-tone dependent for
their circulation. Anatomic studies have shown that 13%
to 15% of women lack valves in the left ovarian vein; thecorresponding figure for the right vein is 6%. When pres-
ent, 43% of the valves on the left and 35% to 41% on the
right are incompetent. Mean values of ovarian venous
diameter are 3.8 mm in the presence of competent valves
and 7.5 mm when the valves are incompetent. The upper
limit of normal diameter for ovarian veins is 5 mm.11
In PCS, the vessels are not only enlarged, but the flow
through them is retarded. Reginald10 showed that these
changes can be temporarily reversed with dihydroergot-
amine intravenously by documenting pelvic venography
and symptoms before and after injection.
Stones12,13 has identified several neurotransmitters pro-
duced by these abnormal vessels. Adenosine 5’ triphos-
phate, substance P, endothelin, and vasopressin have
been found to play a possible role. Calcitonin gene-relat-
ed peptide and nitric oxide have also been implicated.14
SYMPTOMS
Pain is the definitive symptom of PCS. It is usually
described as a dull ache with intermittent acute exacer-
bations. Usually 1 side will predominate, but on careful
questioning, the patient reveals that symptoms are felt
occasionally on the nonpredominate side. The acute
increases in pain will often have a sharp quality. Because
irritable bowel syndrome and endometriosis can also be
present, these pain generators may confuse the patient
and clinician alike. Low backache is often present. All
symptoms are aggravated by anything that increases
venous pressure. Standing, walking, prolonged sitting,
sexual intercourse, and vigorous sports activities will
usually exacerbate the symptoms. These patients will
learn to reduce their activity and will become decondi-
tioned. 
Both deep thrust dyspareunia (71% to78%) and postcoital
aching (65%) are common complaints. This will invari-
ably produce sexual dysfunction and socia-pathology.
Patients may also develop penetration dyspareunia from
vulvovestibulitis as a result of their chronic visceral pain.
Menstrual disorders, such as menorrhagia and
menometrorrhagia, occur in up to 54% of patients.
Intermenstrual bleeding may be present in up to 25%.
Dysmenorrhea of the congestive type will usually begin
up to 1 week before menses (89%) and is described as
low lateral and cramping. This is very similar to the
predysmenorrhea of patients with endometriosis.
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Gastrointestinal and urinary tract symptoms are common.
Bloating, nausea, and diffuse abdominal cramping are
common. Urinary frequency and urgency may be noted.
These are probably a function of the venous engorge-
ment of the peri-vesicle and rectal spaces. Headache,
fatigue, and insomnia may be due to a general auto-
nomic dysfunction. Fibromyalgia can be present.5,11
Psychiatric disturbances may be manifested in a wide
range of symptoms. Anxiety and depression are most
common.
PHYSICAL EXAMINATION
An abdominal examination will produce tenderness over
the ovarian points. This lies at the junction of the upper
and middle third of a line drawn from the anterior supe-
rior iliac crest and the umbilicus. This point is at the level
of the ovarian vein crossing into the bony pelvis, and
compression increases the venous pressure, which exac-
erbates the ovarian tenderness.
On inspection of the external genitalia, superficial vari-
cosities may be noted. Vulvovestibulitis may be present
by Q-tip test.15 Visualization of the cervix may reveal
cyanosis and an increase of cervical mucous. The uterus
and ovaries are tender. The uterus may be retroverted.
The combination of tenderness on abdominal palpation
over the ovarian point and a history of postcoital ache
was 94% sensitive and 77% specific for discriminating
pelvic congestion from other causes of pelvic pain in
Beard’s group. In contrast, Taylor3 reported the most reli-
able sign to be tenderness of the posterior parametrium
and the uterosacral ligaments (80%).11
DIAGNOSTIC STUDIES
The twofold criteria of enlarged veins with reduced cir-
culation require a dynamic diagnostic study that can
measure both. That is why ultrasound, computerized
tomography, magnetic resonance imaging, and radio-
nuclear studies, to date, are inadequate to make an accu-
rate diagnosis.
Laparoscopy is usually done in the Trendelenburg posi-
tion with increased intraabdominal pressure. Therefore,
venous collapse and a false negative impression will
result. If an experienced observer will reverse the head
down position and decrease the insufflation pressure, a
more accurate picture can be achieved.Current Concepts of Pelvic Congestion and Chronic Pelvic Pain, Perry CP.
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Venography should be considered the diagnostic study of
choice. Pelvic venography can be performed transve-
nously or transcervically (transuterine). Beard and col-
leagues16 described a transuterine venogram scoring sys-
tem. This permits an objective standard for pelvic venog-
raphy (Table 1). By measuring the maximum diameter
and the time necessary for the dye to clear, the score can
range from 3 to 9, with 3 or 4 being normal and 5 to 9
suggesting increasingly severe pelvic congestion. A tran-
scervical, transuterine approach is much less expensive
and less invasive than a transvenous approach. The
patient is placed in the dorsal lithotomy position, and a
vaginal speculum exposes the cervical os. This is
cleansed with povidone antiseptic solution, and a special
double lumen needle (Rocket Needle, Rocket Co.,
London, England) is used. The needle is passed through
the cervix via a concentric metal sheath that covers all but
the final 0.5-cm tip. Twenty to 30 mL of water-soluble dye
is injected into the fundal myometrium under fluoro-
scopic guidance. Hyaluronidase may be infused first to
decrease the pressure required for myometrial injection. I
have found this step unnecessary. Some patients may
require conscious sedation for this procedure (about 10%
in my experience). This can be determined by the degree
of tenderness on pelvic examination and by the patient’s
observed response to pain. The first image is taken imme-
diately and then at 20-second intervals for up to 60 sec-
onds. We usually administer an oral antibiotic prophylac-
tically. Beard’s criteria for pelvic congestion is then used
to score the degree of congestion (normal, moderate, or
severe). A new disposable needle may be available short-
ly, which should decrease the risk of infection and sim-
plify the logistics of this procedure. Transuterine injection
is preferable because it demonstrates the uterine vein
component of PCS, which might continue even after
ovarian vein ligation or embolization. This could explain
why the therapies that address only the ovarian compo-
nent, and not the uterine component, of congestion
might produce inadequate pain relief.
With the transvenous approach, sterile technique must be
strictly maintained. After the venous system is accessed
via the femoral of jugular veins, the left renal and subse-
quently left ovarian vein is cannulated. Water-soluble dye
is injected. The right ovarian vein is more difficult and
may require a different type catheter and guide. Unless
the patient is tilted head up, incomplete visualization of
the uterine and paraovarian veins may result. Kennedy
and Hemingway17 described the radiologic criteria for
congestion including: maximal diameter of the ovarian
veins of 10 mm, congestion of the ovarian venous
plexus, filling of the veins across the midline, or filling of
vulvar and thigh varicosities.
TREATMENT
Medical Therapy
Reginald10 found that dihydroergotamine decreased con-
gestion and pain. Because this effect is only transient, no
therapeutic modality has been able to take advantage of
this phenomenon.
Reginald10 treated 22 PCS patients with 30 mg of medrox-
yprogesterone acetate (MPA) daily. Seventeen achieved a
reduction in the pelvic venography score. Those reduc-
ing their score had a corresponding reduction in pain
score 75% of the time. It is not known whether this is
due to the estrogen-blocking effect of MPA or whether
inhibition of the neurotransmitters occurred in these
abnormal veins. This form of therapy is even more suc-
cessful when combined with psychotherapy.18 Weight
gain and depression have been reported by those
patients not tolerating MPA.
Surgical Therapy
Although Taylor3 decried surgical treatment for PCS, lig-
ation of the ovarian veins can be successfully done
through a McBurney incision or may be performed
laparoscopically. In the small number of patients report-
ed to have undergone this procedure, they received
good relief of pain.11 Uterine suspension should be per-
formed laparoscopically in patients with a retroverted
uterus and deep thrust dyspareunia. Hysterectomy with
Table 1.
Scoring system for assessing pelvic venography.16
Score
123
Maximal diameter of 
ovarian veins (mm)  1-4 5-8 >8
Time to disappearance of 
contrast medium after injection
(seconds) 0 20 40
Ovarian plexus congestion  Normal Moderate Extensive bilateral salpingo-oophorectomy has been used success-
fully in some patients. Beard19 reported 36 women who
had failed medical management and went on to hys-
terectomy with bilateral salpingo-oophorectomy. All
patients except 1 experienced good pain relief at 1 year
postoperation. However, because these patients are
young, more conservative initial therapy is appropriate.
Embolotherapy
Edwards20 was the first to report radiologic transvenous
embolization of the ovarian veins to treat PCS. In all, 56
patients have now been reported.5 The majority of these
patients received good relief. The only complications
have been hematoma at the puncture sight (1) and ovar-
ian vein perforation (2). The procedure is similar to
transvenous selective venography, but either enbucrilate
(Histoacryl L Transparent, B. Braun, Melsungen,
Germany) or small 5- to 15-mm stainless steel coils
(Gianturco Coils, Cook Inc., Bloomington, IN), or the
combination of the 2 are injected. Most experts do not
recommend the use of sclerosing agents, to avoid inad-
vertent systemic dissemination.
CONCLUSION
The widely variable symptoms and the strong association
with psychological disturbances have caused many gyne-
cologists to question the legitimacy of this condition.5,11
The preponderance of evidence now favors its further
investigation.
Pelvic congestion syndrome may not be as uncommon as
previously assumed. In patients with chronic pelvic pain
and no visible pathology at laparoscopy, pelvic venogra-
phy should be performed. Also, those patients with other
pain generators not responding to conventional therapy
should be studied if indicated by history or physical
examination. Women’s health care providers should
become educated about this condition and approach its
diagnosis and management with an open mind. Only
then will we see a reduction in the suffering of these
patients.
Pelvic venography should be available and the transuter-
ine approach used when possible. Medical therapy with
medroxyprogesterone acetate should be given for at least
3 months before surgical therapy is used. Laparoscopic
venous ligation or embolotherapy should be selected for
those patients not responding to MPA.
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